Sanofi

Products

Category

Product

Brand

Description

Neurology Market: A BCC Research Overview (PHM215B)

AUBAGIO (teriflunomide)		Adults with relapsing forms of multiple sclerosis (MS), such as clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, can be treated with AUBAGIO, a pyrimidine synthesis inhibitor.
LEMTRADA (alemtuzumab)		A CD52-directed cytolytic monoclonal antibody called LEMTRADA is prescribed to treat relapsing types of multiple sclerosis (MS) in adults, such as relapsing-remitting disease and active secondary progressive disease.

This information is available for BCC Research members only.

Already a Member? Sign In Become a Member

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment